VIMOVO

Nchi: Israeli

Lugha: Kiingereza

Chanzo: Ministry of Health

Nunua Sasa

Viambatanisho vya kazi:

ESOMEPRAZOLE AS MAGNESIUM TRIHYDRATE 20 MG; NAPROXEN 500 MG

Inapatikana kutoka:

ASTRA ZENECA ISRAEL LTD

ATC kanuni:

G02CC02

Dawa fomu:

TABLETS MODIFIED RELEASE

Njia ya uendeshaji:

PER OS

Viwandani na:

ASTRA ZENECA AB., SWEDEN

Kundi la matibabu:

NAPROXEN

Matibabu dalili:

Vimovo is a combination product that contains naproxen and esomeprazole. It is indicated for the relief of signs and symptoms of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis and to decrease the risk of developing gastric ulcers in patients at risk of developing NSAID-associated gastric ulcers. Vimovo is not recommended for initial treatment of acute pain because the absorption of naproxen is delayed compared to absorption from other naproxen-containing products.

Idhini ya tarehe:

2011-12-01

Tafuta arifu zinazohusiana na bidhaa hii

Tazama historia ya hati